Morgan Stanley (MS) recently experienced a daily decline of 2.82%, underperforming the S&P 500, and has seen a 0.13% decrease over the past month, lagging its sector. Despite this recent stock performance, the investment bank is projected to report robust Q3 2025 earnings with an EPS of $2.07, a 10.11% year-over-year increase, and revenue of $16.4 billion, up 6.61%. However, the Zacks Consensus EPS estimate has slightly decreased by 0.01% in the last month, and MS currently trades at a premium valuation with a Forward P/E of 17.63 and a PEG ratio of 1.82 compared to industry averages, holding a Zacks Rank of #3 (Hold).
Morgan Stanley (MS) recently experienced a daily decline of 2.82%, underperforming the S&P 500's 2.71% loss and the Nasdaq's 3.56% depreciation. Over the past month, MS stock dropped 0.13%, lagging the Finance sector's 0.28% gain and the S&P 500's 3.5% gain, indicating a period of relative underperformance. Despite recent stock weakness, MS is forecasted to report strong upcoming earnings, with its Q3 2025 EPS projected at $2.07, a 10.11% year-over-year increase. Net sales are expected to reach $16.4 billion, up 6.61% from the year-ago period, while full-year estimates project EPS of $8.86 (+11.45%) and revenue of $67.26 billion (+8.91%). However, MS trades at a premium valuation, with a Forward P/E of 17.63 compared to the industry average of 16.58, and a PEG ratio of 1.82 versus the industry's 1.47. The Zacks Consensus EPS estimate saw a slight 0.01% decrease over the past month, contributing to its current Zacks Rank of #3 (Hold), though the Financial - Investment Bank industry holds a strong Zacks Industry Rank of 33. The upcoming earnings release on October 15, 2025, will be crucial for validating these growth projections against the current valuation and recent stock performance. The slight downward revision in EPS estimates, despite overall positive growth forecasts, warrants attention.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Overall Sentiment
mixed
Sentiment Score
0.00
Ticker Sentiment